4Robertson B.Corticosteroids and surfactant for prevention of NRDS[J].Ann Med,1999,25(3):285-288.
二级参考文献9
1Committee on Fetus and Newborn of American Academy of Pediatrics. Surfactant replacement therapy for respiratory distress syndrome. Pediatrics, 1999,103 : 684.
2Kim ES,Stolar CJ. ECMO in the newborn. Am J Perinatol, 2000,17(7):345.
3O'Shea TM,Doyle LW. Perinatal glucocorticoid therapy and neurodevelopmental outcome: an epidemiologic perspective. Semin Neonatol, 2001,6(4) :293.
4Hansen T,Corbet A. Disorders of the transition. In:Taeusch HW,Ballard R,eds. Avery' s diseases of the newborn. 7th ed. Harcourt Asia: WB Saunders, 1999. 602.
5Jeena P, Pillay P, Adhikari M. Nasal CPAP in newborns with acute respiratory failure. Ann Trop Paediatr,2002,22(3):201.
6McGettigan MC,Adolph VR,Ginsber HG, et al. New ways to ventilate newborns in acute respiratory failure. Pediatr Clin North Am,1998,45(3) :475.
7Courtney SE,Durand DJ ,Asselin JM,et al. High-frequency oscillatory ventilation versus conventional mechanical ventilation for verylow-birth-weight infants. N Engl J Med, 2002,347 (9) : 643.
8Joris N. Sndre P, Mcessinger A. Early application of CPAP in newborns with gestational below 34 weeks lowers intubation rate and shortens oxygen therapy without altering mortality and morbidity[J]. Schweiz Med Wochenschr, 2000,130 (49):1887-1893.
9Keen A. Cantiaons positive airway pressure in the intensive care unit-uses and implications for nursing management [J]. Nurs Crit Care, 2000, 5(3) :137-141.
